JPWO2019203255A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019203255A5
JPWO2019203255A5 JP2020514407A JP2020514407A JPWO2019203255A5 JP WO2019203255 A5 JPWO2019203255 A5 JP WO2019203255A5 JP 2020514407 A JP2020514407 A JP 2020514407A JP 2020514407 A JP2020514407 A JP 2020514407A JP WO2019203255 A5 JPWO2019203255 A5 JP WO2019203255A5
Authority
JP
Japan
Prior art keywords
cancer
cells
administration
emt
anticancer drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020514407A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019203255A1 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/016421 external-priority patent/WO2019203255A1/ja
Publication of JPWO2019203255A1 publication Critical patent/JPWO2019203255A1/ja
Publication of JPWO2019203255A5 publication Critical patent/JPWO2019203255A5/ja
Pending legal-status Critical Current

Links

JP2020514407A 2018-04-19 2019-04-17 再構成癌組織を用いた薬剤評価方法 Pending JPWO2019203255A1 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018080585 2018-04-19
JP2018080585 2018-04-19
PCT/JP2019/016421 WO2019203255A1 (ja) 2018-04-19 2019-04-17 再構成癌組織を用いた薬剤評価方法

Publications (2)

Publication Number Publication Date
JPWO2019203255A1 JPWO2019203255A1 (ja) 2021-06-10
JPWO2019203255A5 true JPWO2019203255A5 (https=) 2022-03-02

Family

ID=68238962

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020514407A Pending JPWO2019203255A1 (ja) 2018-04-19 2019-04-17 再構成癌組織を用いた薬剤評価方法

Country Status (2)

Country Link
JP (1) JPWO2019203255A1 (https=)
WO (1) WO2019203255A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7702110B2 (ja) * 2020-04-28 2025-07-03 国立大学法人高知大学 ヒト膵癌オルガノイドを用いたマウスモデルの樹立
US20220276225A1 (en) * 2020-06-25 2022-09-01 Next & Bio Inc. Method for providing information necessary for diagnosing cancer patient's resistance to anti-cancer agent and/or radiation
EP4253516A3 (en) 2020-06-25 2023-12-06 Next & Bio Inc. Method for mass proliferation of stem cells without using hydrogel
US12606783B2 (en) 2020-06-25 2026-04-21 Next & Bio Inc. Well plate and 3D culture plate comprising the same
KR102746473B1 (ko) 2021-07-09 2024-12-26 주식회사 넥스트앤바이오 가상 오가노이드를 이용한 촬영 이미지 데이터 생성 방법
KR102746470B1 (ko) 2021-07-09 2024-12-26 주식회사 넥스트앤바이오 가상 오가노이드 생성 방법
WO2023238939A1 (ja) * 2022-06-09 2023-12-14 慶應義塾 癌の再燃若しくは再発の予防剤又は治療剤及びそのスクリーニング方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014151606A2 (en) * 2013-03-15 2014-09-25 Oncomed Pharmaceuticals, Inc. Methods of treating pancreatic cancer
US20170023576A1 (en) * 2014-04-04 2017-01-26 Oncomed Pharmaceuticals, Inc. Notch3 antibodies and uses thereof
WO2016089208A2 (en) * 2014-12-04 2016-06-09 Stichting Maastricht Radiation Oncology "Maastro-Clinic" Sulfonamide, sulfamate and sulfamide derivatives of anti-cancer agents

Similar Documents

Publication Publication Date Title
JPWO2019203255A5 (https=)
Sun et al. Therapeutic strategies targeting cancer stem cells and their microenvironment
Wei et al. Large-scale and rapid preparation of nanofibrous meshes and their application for drug-loaded multilayer mucoadhesive patch fabrication for mouth ulcer treatment
JP2019150584A5 (https=)
Jiang et al. Metformin and docosahexaenoic acid hybrid micelles for premetastatic niche modulation and tumor metastasis suppression
Srivastava et al. Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens
Dang et al. Local doxorubicin delivery via 3D‐printed porous scaffolds reduces systemic cytotoxicity and breast cancer recurrence in mice
EP3750540A1 (en) Choroidal neovascularization suppressor or drusen formation suppressor
Cheikh et al. Lessons learned from the discovery and development of the sesquiterpene lactones in cancer therapy and prevention
Guo et al. Choline protects the heart from doxorubicin‐induced cardiotoxicity through vagal activation and Nrf2/HO‐1 pathway
Stewart et al. Cytocidal activity and proliferative ability of macrophages infiltrating the EMT6 tumor
Shin et al. Immunomodulatory effects of perioperative dexmedetomidine in ovarian cancer: an in vitro and xenograft mouse model study
Qian et al. Ginsenosides: an immunomodulator for the treatment of colorectal cancer
Choi et al. Studies on the anti-inflammatory effects of Clerodendron trichotomum Thunberg leaves
He et al. Tumor-associated macrophages in colon cancer immunotherapy: Mechanisms, natural product interventions, and microenvironment remodeling
Yin et al. Nourishment of nerves and innervation: A novel approach for the treatment of myocardial infarction
Naghinezhad PI3K/AKT/mTOR pathway in ATLL: from basic biology to preclinical study
DK2919791T3 (da) Delphinidin-kompleks som antiflogistisk eller immunsuppressivt aktivt stof
Gangwar et al. Utilizing guar gum for development of “tabs in cap’system of losartan potassium for chronotherapeutics
Ansari et al. Targeting breast cancer signaling via phytomedicine and nanomedicine
Katsuyama et al. Intraplantar injection of linalool reduces paclitaxel-induced acute pain in mice
Xu et al. Schisandrin C prevents regorafenib-induced cardiotoxicity by recovering EPHA2 expression in cardiomyocytes
Sailo et al. Molecular alterations involved in pancreatic cancer chemoresistance and chemosensitization strategies
Stephen et al. A comparative study of once daily versus twice daily tacrolimus in liver transplantation
Khanal et al. Current Insights of the Potential Plant Bioactive Compounds on Modulating the mTOR Signaling Pathway in Regulating Oncological Disorders